LCMV (33–41), GP33 - 1 mg
- Cat.Number : AS-61669
- Manufacturer Ref. :
-
Availability :
In stock
Alternative choices
This is the H-2Db restricted epitope derived from the Lymphocytic Choreomeningitis Virus (LCMV) glycoprotein gp 33; residues 33 to 41.
Specifications
Chemistry | |
Sequence one letter code |
|
---|---|
Sequence three letter code |
|
Molecular Formula |
|
Molecular Mass/ Weight |
|
Modification | |
Conjugation |
|
Quantity & Purity | |
Purity |
|
Storage & stability | |
Form |
|
Storage Conditions |
|
Activity | |
Biomarker Target | |
Research Area | |
Sub-category Research Area | |
Usage |
|
Source | |
Source / Species |
|
You may also be interested in the following product(s)



Citations
Puromycin-Sensitive Aminopeptidase Limits MHC Class I Presentation in Dendritic Cells but Does Not Affect CD8 T Cell Responses during Viral Infections
J Immunol . 2008 Feb 01 ; 180(3) 1704 | DOI : 10.4049/jimmunol.180.3.1704
- CF. Towne
Analysis of the Role of Bleomycin Hydrolase in Antigen Presentation and the Generation of CD8 T Cell Responses.
J Immunol . 2007 Jun 01 ; 178(11) 6923 | DOI : 10.4049/jimmunol.178.11.6923
- CF. Towne
References
Differential Tissue-Specific Regulation of Antiviral CD8+ T-Cell Immune Responses during Chronic Viral Infection
J Virol . 2004 Apr 01 ; 78(7) 3578 | DOI : https://doi.org/10.1128/JVI.78.7.3578-3600.2004
- S. Zhou
- et al
Expansion of Protective CD8+ T-Cell Responses Driven by Recombinant Cytomegaloviruses
J Virol . 2004 Mar 01 ; 78(5) 2255 | DOI : https://doi.org/10.1128/JVI.78.5.2255-2264.2004
- U. Karrer
- et al